Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

LINCOMYCIN HYDROCHLORIDE

LINCOMYCIN HYDROCHLORIDE

Standard Dose
EQ 300MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LINCOMYCIN HYDROCHLORIDE is listed in Drugs@FDA under application 216662 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LINCOMYCIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 300MG BASE/ML Sponsor SLATE RUN PHARMA Submission history Latest submission status date: 2022-12-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview LINCOMYCIN HYDROCHLORIDE is listed in Drugs@FDA under application 216662 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LINCOMYCIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 300MG BASE/ML Sponsor SLATE RUN PHARMA Submission history Latest submission status date: 2022-12-21 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.